Psychogeriatrics, Journal Year: 2025, Volume and Issue: 25(3)

Published: April 7, 2025

Abstract Loss of memory is the main feature dementia, accompanied by personality changes. Alzheimer's disease (AD) most prevalent type dementia globally and a major contributor to disability mortality in older individuals. Most notably, neurological damage caused AD irreversible, but current market still lacks effective medications for treatment dementia. Numerous research studies have indicated that inflammatory response significantly involved development cognitive impairment, elevated C‐reactive protein (CRP) levels healthy people increases likelihood future AD. CRP nonspecific indicator inflammation. In clinical practice, has long been proven be one risk factors powerful predictors neurodegenerative diseases. Given accessibility cost‐effectiveness testing, it reasonable anticipate its utilisation early screening monitoring progression future. This review therefore focuses on specific relationship between various types explores how contributes impairment.

Language: Английский